Presence and activity of cytochrome P450 isoforms in minipig liver microsomes -: Comparison with human liver samples

被引:0
|
作者
Anzenbacher, P
Soucek, P
Anzenbacherová, E
Gut, I
Hruby, K
Svoboda, Z
Kvetina, J
机构
[1] Acad Sci, PRO MED CS Praha, Inst Expt Biopharmaceut, Prague, Czech Republic
[2] Natl Inst Publ Hlth, Oslo, Norway
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cytochrome P450 (CYP) of the 3A family (CYP3A) has been detected in minipig liver microsomes by immunochemical screening (Western blotting), revealing bands that co-migrate with human CYP3A4 and 3A5, The nifedipine oxidase activity and testosterone 6 beta-hydroxylating activity (specific markers for CYP3A enzymes) of the human liver microsomal and minipig liver microsomal samples were comparable, as were the results of specific inhibition of this activity by triacetyloleandomycin. The presence of CYP1A, 2A, 2C, 2D, and 2E1 marker activities in minipig liver microsomes was found by testing with the respective specific substrates (7-ethoxyresorufin, coumarin, tolbutamide, bufuralol, and chlorzoxazone). 7-Pentoxyresorufin O-depentylase activity (indicative of CYP2B) was absent from minipig as well as human liver microsomal samples. The results indicate that minipigs might be, in many cases, the most suitable experimental animals to predict biotransformation pathways in humans, because the activity of the most important CYP isoform in humans (CYP3A, metabolizing the majority of known drug substrates) is present in minipigs, with comparable levels and activities, Moreover, there is no need to induce CYP enzyme levels.
引用
收藏
页码:56 / 59
页数:4
相关论文
共 50 条
  • [1] In vitro metabolism of nonane by human liver microsomes and cytochrome P450 isoforms
    Edwards, JE
    Rose, RL
    Hodgson, E
    DRUG METABOLISM REVIEWS, 2004, 36 : 156 - 156
  • [2] Cytochrome P450 isoforms involved in melatonin metabolism in human liver microsomes
    Gabriella Facciolá
    Mats Hidestrand
    Christer von Bahr
    Gunnel Tybring
    European Journal of Clinical Pharmacology, 2001, 56 : 881 - 888
  • [3] Cytochrome P450 isoforms involved in melatonin metabolism in human liver microsomes
    Facciolá, G
    Hidestrand, M
    von Bahr, C
    Tybring, G
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 56 (12) : 881 - 888
  • [4] In vitro metabolism of clomethiazole by human liver microsomes and human cytochrome P450 isoforms
    Hagbjörk, AL
    Ågren, J
    Andersson, A
    Terelius, Y
    DRUG METABOLISM REVIEWS, 2003, 35 : 121 - 121
  • [5] Inhibitory effect of glyburide on human cytochrome P450 isoforms in human liver microsomes
    Kim, KA
    Park, JY
    DRUG METABOLISM AND DISPOSITION, 2003, 31 (09) : 1090 - 1092
  • [6] In vitro metabolism of bepridil by human liver microsomes and human cytochrome P450 isoforms
    Gopaul, VS
    Baumgardner, DL
    Wu, WN
    Streeter, AJ
    DRUG METABOLISM REVIEWS, 2004, 36 : 208 - 208
  • [7] Stereoselective metabolism of endosulfan by human liver microsomes and human cytochrome P450 isoforms
    Lee, Hwa-Kyung
    Moon, Joon-Kwan
    Chang, Chul-Hee
    Choi, Hoon
    Park, Hee-Won
    Park, Byeoung-Soo
    Lee, Hye-Suk
    Hwang, Eul-Chul
    Lee, Young-Deuk
    Liu, Kwang-Hyeon
    Kim, Jeong-Han
    DRUG METABOLISM AND DISPOSITION, 2006, 34 (07) : 1090 - 1095
  • [8] In vitro metabolism of alachlor by human liver microsomes and human cytochrome P450 isoforms
    Coleman, S
    Liu, SM
    Linderman, R
    Hodgson, E
    Rose, RL
    CHEMICO-BIOLOGICAL INTERACTIONS, 1999, 122 (01) : 27 - 39
  • [9] Stereoselective metabolism of endosulfan by human liver microsomes and human cytochrome P450 isoforms
    Lee, Hwa-Gyung
    Kim, Jeong-Han
    Moon, Joon-Kwan
    Chang, Chul-Hee
    Choi, Hoon
    Park, Hee-Won
    Park, Byeong-Soo
    Hwang, Eul-Chul
    Lee, Hye-Suk
    Lee, Young-Deuk
    Liu, Kwang-Hyeon
    DRUG METABOLISM REVIEWS, 2006, 38 : 186 - 186
  • [10] Identification of cytochrome P450 isoforms involved in the metabolism of loperamide in human liver microsomes
    Kyoung-Ah Kim
    Jaegul Chung
    Dong-Hae Jung
    Ji-Young Park
    European Journal of Clinical Pharmacology, 2004, 60 : 575 - 581